|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Ben-Chetrit N, Tarcic G and Yarden Y:
ERK-ERF-EGR1, a novel switch underlying acquisition of a motile
phenotype. Cell Adh Migr. 7:33–37. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Thu KL, Radulovich N, Becker-Santos DD, et
al: SOX15 is a candidate tumor suppressor in pancreatic cancer with
a potential role in Wnt/β-catenin signaling. Oncogene. 33:279–288.
2014.PubMed/NCBI
|
|
4
|
Hill KS, Erdogan E, Khoor A, et al:
Protein kinase Cα suppresses Kras-mediated lung tumor formation
through activation of a p38 MAPK-TGFβ signaling axis. Oncogene. Apr
22–2013.(Epub ahead of print).
|
|
5
|
Nojima M, Suzuki H, Toyota M, et al:
Frequent epigenetic inactivation of SFRP genes and
constitutive activation of Wnt signaling in gastric cancer.
Oncogene. 26:4699–4713. 2007.PubMed/NCBI
|
|
6
|
Xu G, Zhang W, Bertram P, Zheng XF and
McLeod H: Pharmacogenomic profiling of the PI3K/PTEN-AKT-mTOR
pathway in common human tumors. Int J Oncol. 24:893–900.
2004.PubMed/NCBI
|
|
7
|
Krützfeldt J, Poy MN and Stoffel M:
Strategies to determine the biological function of microRNAs. Nat
Genet. 38:S14–S19. 2006.
|
|
8
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Carthew RW: Gene regulation by microRNAs.
Curr Opin Genet Dev. 16:203–208. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hayashita Y, Osada H, Tatematsu Y, et al:
A polycistronic microRNA cluster, miR-17–92, is overexpressed in
human lung cancers and enhances cell proliferation. Cancer Res.
65:9628–9632. 2005.
|
|
11
|
Lee YS and Dutta A: The tumor suppressor
microRNA let-7 represses the HMGA2 oncogene. Genes Dev.
21:1025–1030. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nan Y, Han L, Zhang A, et al: miRNA-451
plays a role as tumor suppressor in human glioma cells. Brain Res.
1359:14–21. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang JG, Guo JF, Liu DL, Liu Q and Wang
JJ: MicroRNA-101 exerts tumor-suppressive functions in non-small
cell lung cancer through directly targeting enhancer of zeste
homolog 2. J Thorac Oncol. 6:671–678. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chan SH, Wu CW, Li AF, Chi CW and Lin WC:
miR-21 microRNA expression in human gastric carcinomas and its
clinical association. Anticancer Res. 28:907–911. 2008.PubMed/NCBI
|
|
15
|
Katada T, Ishiguro H, Kuwabara Y, et al:
microRNA expression profile in undifferentiated gastric cancer. Int
J Oncol. 34:537–542. 2009.PubMed/NCBI
|
|
16
|
Xia L, Zhang D, Du R, et al: miR-15b and
miR-16 modulate multidrug resistance by targeting BCL2 in human
gastric cancer cells. Int J Cancer. 123:372–379. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cho WJ, Shin JM, Kim JS, et al: miR-372
regulates cell cycle and apoptosis of ags human gastric cancer cell
line through direct regulation of LATS2. Mol Cells. 28:521–527.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu Q, Jin H, Yang Z, et al: MiR-150
promotes gastric cancer proliferation by negatively regulating the
pro-apoptotic gene EGR2. Biochem Biophys Res Commun. 392:340–345.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Varambally S, Cao Q, Mani RS, et al:
Genomic loss of microRNA-101 leads to overexpression of histone
methyltransferase EZH2 in cancer. Science. 322:1695–1699. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang Z, Li Z, Gao C, et al: miR-21 plays
a pivotal role in gastric cancer pathogenesis and progression. Lab
Invest. 88:1358–1366. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Du Y, Xu Y, Ding L, Yao H, Yu H, Zhou T
and Si J: Down-regulation of miR-141 in gastric cancer and its
involvement in cell growth. J Gastroenterol. 44:556–561. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Takahashi Y, Forrest AR, Maeno E,
Hashimoto T, Daub CO and Yasuda J: miR-107 and miR-185 can induce
cell cycle arrest in human non small cell lung cancer cell lines.
PLoS One. 4:e66772009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ding L, Xu Y, Zhang W, et al: MiR-375
frequently downregulated in gastric cancer inhibits cell
proliferation by targeting JAK2. Cell Res. 20:784–793. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tie J, Pan Y, Zhao L, et al: MiR-218
inhibits invasion and metastasis of gastric cancer by targeting the
Robo1 receptor. PLoS Genet. 6:e10008792010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
BouKheir T, Futoma-Kazmierczak E, Jacobsen
A, et al: miR-449 inhibits cell proliferation and is down-regulated
in gastric cancer. Mol Cancer. 10:292011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Reddy SD, Ohshiro K, Rayala SK and Kumar
R: MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase
1 and regulates its functions. Cancer Res. 68:8195–8200. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Saydam O, Senol O, Würdinger T, et al:
miRNA-7 attenuation in Schwannoma tumors stimulates growth by
upregulating three oncogenic signaling pathways. Cancer Res.
71:852–861. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xiong S, Zheng Y, Jiang P, Liu R, Liu X
and Chu Y: MicroRNA-7 inhibits the growth of human non-small cell
lung cancer A549 cells through targeting BCL-2. Int J Biol Sci.
7:805–814. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jiang L, Liu X, Chen Z, et al: MicroRNA-7
targets IGF1R (insulin-like growth factor 1 receptor) in tongue
squamous cell carcinoma cells. Biochem J. 432:199–205. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lu J, Getz G, Miska EA, et al: MicroRNA
expression profiles classify human cancers. Nature. 435:834–838.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yao Y, Suo AL, Li ZF, et al: MicroRNA
profiling of human gastric cancer. Mol Med Rep. 2:963–970.
2009.PubMed/NCBI
|
|
32
|
Guo XB, Jing CQ, Li LP, et al:
Down-regulation of miR-622 in gastric cancer promotes cellular
invasion and tumor metastasis by targeting ING1 gene. World J
Gastroenterol. 17:1895–1902. 2011.PubMed/NCBI
|
|
33
|
Kong D, Piao YS, Yamashita S, et al:
Inflammation-induced repression of tumor suppressor miR-7 in
gastric tumor cells. Oncogene. 31:3949–3960. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shin VY, Jin H, Ng EK, et al: NF-κB
targets miR-16 and miR-21 in gastric cancer: involvement of
prostaglandin E receptors. Carcinogenesis. 32:240–245. 2011.
|
|
35
|
Inoue T, Iinuma H, Ogawa E, Inaba T and
Fukushima R: Clinicopathological and prognostic significance of
microRNA-107 and its relationship to DICER1 mRNA expression in
gastric cancer. Oncol Rep. 27:1759–1764. 2012.PubMed/NCBI
|
|
36
|
Liu K, Qian T, Tang L, Wang J, Yang H and
Ren J: Decreased expression of microRNA let-7i and its association
with chemotherapeutic response in human gastric cancer. World J
Surg Oncol. 10:2252012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Deng H, Guo Y, Song H, et al: MicroRNA-195
and microRNA-378 mediate tumor growth suppression by epigenetical
regulation in gastric cancer. Gene. 518:351–359. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Matsuo M, Nakada C, Tsukamoto Y, et al:
MiR-29c is downregulated in gastric carcinomas and regulates cell
proliferation by targeting RCC2. Mol Cancer. 12:152013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xia J, Wu Z, Yu C, et al: miR-124 inhibits
cell proliferation in gastric cancer through down-regulation of
SPHK1. J Pathol. 227:470–480. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Feng R, Chen X, Yu Y, et al: miR-126
functions as a tumour suppressor in human gastric cancer. Cancer
Lett. 298:50–63. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sacconi A, Biagioni F, Canu V, et al:
miR-204 targets Bcl-2 expression and enhances responsiveness of
gastric cancer. Cell Death Dis. 3:e4232012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Catalano V, Labianca R, Beretta GD, Gatta
G, de Braud F and Van Cutsem E: Gastric cancer. Crit Rev Oncol
Hematol. 71:127–164. 2009. View Article : Google Scholar
|
|
43
|
Zhao X, Dou W, He L, et al: MicroRNA-7
functions as an anti-metastatic microRNA in gastric cancer by
targeting insulin-like growth factor-1 receptor. Oncogene.
32:1363–1372. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Webster RJ, Giles KM, Price KJ, Zhang PM,
Mattick JS and Leedman PJ: Regulation of epidermal growth factor
receptor signaling in human cancer cells by microRNA-7. J Biol
Chem. 284:5731–5741. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Giles KM, Barker A, Zhang PM, Epis MR and
Leedman PJ: MicroRNA regulation of growth factor receptor signaling
in human cancer cells. Methods Mol Biol. 676:147–163. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Nicholson RI, Gee JM and Harper ME: EGFR
and cancer prognosis. Eur J Cancer. 37:S9–S15. 2001. View Article : Google Scholar
|
|
47
|
Saif MW: Colorectal cancer in review: the
role of the EGFR pathway. Expert Opin Investig Drugs. 19:357–369.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lieto E, Ferraraccio F, Orditura M, et al:
Expression of vascular endothelial growth factor (VEGF) and
epidermal growth factor receptor (EGFR) is an independent
prognostic indicator of worse outcome in gastric cancer patients.
Ann Surg Oncol. 15:69–79. 2008. View Article : Google Scholar
|
|
49
|
Arkenau HT: Gastric cancer in the era of
molecularly targeted agents: current drug development strategies. J
Cancer Res Clin Oncol. 135:855–866. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
She QB, Solit DB, Ye Q, O’Reilly KE, Lobo
J and Rosen N: The BAD protein integrates survival signaling by
EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor
cells. Cancer Cell. 8:287–297. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Corcoran RB, Ebi H, Turke AB, et al:
EGFR-mediated re-activation of MAPK signaling contributes to
insensitivity of BRAF mutant colorectal cancers to RAF inhibition
with vemurafenib. Cancer Discov. 2:227–235. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kim MA, Lee HS, Lee HE, Jeon YK, Yang HK
and Kim WH: EGFR in gastric carcinomas: prognostic significance of
protein overexpression and high gene copy number. Histopathology.
52:738–746. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Toulany M, Dittmann K, Krüger M, Baumann M
and Rodemann HP: Radioresistance of K-Ras mutated human tumor cells
is mediated through EGFR-dependent activation of PI3K-AKT pathway.
Radiother Oncol. 76:143–150. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Donovan JC, Milic A and Slingerland JM:
Constitutive MEK/MAPK activation leads to p27Kip1
deregulation and antiestrogen resistance in human breast cancer
cells. J Biol Chem. 276:40888–40895. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Stamenkovic I: Matrix metalloproteinases
in tumor invasion and metastasis. Semin Cancer Biol. 10:415–433.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Pires MM, Hopkins BD, Saal LH and Parsons
RE: Alterations of EGFR, p53 and PTEN that mimic changes found in
basal-like breast cancer promote transformation of human mammary
epithelial cells. Cancer Biol Ther. 14:246–253. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Britschgi A, Bill A, Brinkhaus H, et al:
Calcium-activated chloride channel ANO1 promotes breast cancer
progression by activating EGFR and CAMK signaling. Proc Natl Acad
Sci USA. 110:E1026–E1034. 2013. View Article : Google Scholar : PubMed/NCBI
|
